Anti-Cancer Agents
Phase I Trials of Anti-Cancer Agents
- funding agency: National Cancer Institute
- date: 03/2003 - 01/2008
- grant amount: $592,143.00
This project conducts correlative studies to evaluate clinical outcomes in the context of basic science observations. Studies done under this project will advance new therapies from the bench to the bedside and provide insights into cancer biology.
- Project Investigators:
- Joel Saltz, M.D., Ph.D.
- Michael Grever (PI)
[edit grant]